Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: The Use of Narrative in Public Health Research and Practice: Patient Experience of Wellness Acupuncture
A NCCIH-sponsored clinical trial evaluating narrative approaches in public health research and practice, focusing on patient experiences of …
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Use of Complementary and Alternative Medicine Among Older Mexican Americans
This ClinicalTrials.gov entry reports that the study on complementary and alternative medicine use among older Mexican Americans sponsored b…
-
CLINICAL_TRIALS trial_result · 2006-07-27Clinical Trial Update: Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine [Phase 4]
Phase 4 trial assessing whether paroxetine prophylaxis prevents interferon-induced depression in patients with major depressive disorder; st…
-
CLINICAL_TRIALS trial_result · 2006-07-25Clinical Trial Update: Duloxetine in the Treatment of Melancholic Depression [Phase 3]
A Phase 3 trial evaluating duloxetine for major depressive disorder with melancholic features has completed, sponsored by Eli Lilly and Comp…
-
CLINICAL_TRIALS trial_result · 2006-07-25Clinical Trial Update: Switching to Duloxetine From Other Antidepressants [Phase 4]
A Phase 4 trial evaluated outcomes of switching patients with Major Depressive Disorder from other antidepressants to duloxetine, sponsored …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-07-24Clinical Trial Update: The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression [Phase 3]
This update notes the completion of a Phase 3 study evaluating the fixed-dose combination of olanzapine and fluoxetine for treatment-resista…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression [Phase 3]
Phase 3 clinical trial update evaluating dose escalation and safety of duloxetine hydrochloride given once daily for major depressive disord…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia [Phase 4]
A Phase 4 trial comparing olanzapine to an active comparator in depression associated with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression [Phase 3]
Open-label Phase 3 trial evaluating once-daily duloxetine for stabilization dosing in adults with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating duloxetine versus placebo for prevention of relapse in major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2006-07-13Clinical Trial Update: Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders [Phase 2]
This Phase 2 study evaluated repetitive transcranial magnetic stimulation (rTMS) for mood disorders and has completed. It included condition…
-
CLINICAL_TRIALS trial_result · 2006-06-09Clinical Trial Update: A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. [Phase 4]
A Phase 4 placebo-controlled trial of ropinirole for refractory bipolar depression is being conducted at Sheba Medical Center; the trial sta…
-
CLINICAL_TRIALS trial_result · 2006-05-22Clinical Trial Update: Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression [Phase 3]
A Phase 3 trial evaluating an anti-Toxoplasma gondii add-on therapy in Toxoplasma seropositive individuals with schizophrenia or major depre…
-
CLINICAL_TRIALS trial_result · 2006-05-18Clinical Trial Update: Use of Risperidone in ECT for Treatment Resistant Depression [Phase 4]
Phase 4 trial evaluating risperidone augmentation with electroconvulsive therapy for treatment-resistant depression was terminated.